Ascom wins largest ever Ascom Myco 2 order: 4 000 units to be implemented at Norwegian hospital

November 29, 2017

Ascom wins the single largest ever Ascom Myco order. 4 000 Ascom Myco 2 smart devices will be delivered through a business partner to the St. Olavs Hospital in Trondheim and used to improve the workflow of caregivers.

The entire frame agreement has a value of around CHF 4.8 million and the smart devices will be delivered to Hemit, the IT department at the Central Norway Regional Health Authority. The shipment of the first batch of 4 000 Ascom Myco 2 to St. Olavs Hospital starts in December. Implementation of the mobile smart devices will be completed with an integration to hospital's existing messaging system securing fast and safe handling of critical alarms and messaging.

The Ascom Myco 2 is a mobile smart device and a key part of the Ascom Healthcare platform. Ascom Myco 2 features sophisticated technologies including near-field communication (NFC), infrared (IR) positioning and an updated operating system to simplify healthcare workflows for caregivers.

"Alarm handling in mobile smart devices has become crucial for improving patient care and optimizing workflows. Having the Central Norway Regional Health Authority implementing Ascom Myco 2 fits very well with our ambition to drive mobile workflow innovation in hospitals", says Aage Rask Andersen, Managing Director of Ascom Nordics.

For more information about the Ascom Healthcare Platform and Ascom Myco 2 visit: https://www.ascom.com/marketing-campaigns/en-us/ascom-myco-2.html

Back to list

Download

This document does not constitute an offer or solicitation to subscribe for, purchase or sell any securities. This document is not being issued in the United States of America or the United Kingdom and should not be distributed in any jurisdiction in a manner where such distribution would not comply with regulatory requirements. In particular, this document may not be distributed into the United States, to United States persons or to publications with a general circulation in the United States. In addition, the securities of Ascom have not been and will not be registered in any jurisdiction outside Switzerland. The securities of Ascom may not be offered, sold or delivered and no solicitation to purchase such securities may be made within the United States or to U.S. persons absent an applicable exemption from the registration requirements of the United States securities laws or within any other jurisdiction and in a manner where such offer, sale, delivery or solicitation might not be in compliance with regulatory requirements (including the United Kingdom).

News